Collegium Pharmaceutical appoints Vikram Karnani as CEO
The Fly

Collegium Pharmaceutical appoints Vikram Karnani as CEO

Collegium Pharmaceutical (COLL) announced that Vikram Karnani has been appointed as president and CEO of Collegium and will join its board of directors effective November 12. Michael Heffernan, who has served as interim president and CEO since May, will remain chairman of the board. Vikram Karnani most recently served as EVP and president, global commercial operations and medical affairs at Amgen (AMGN).

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App